13F HOLDINGS REPORT
Deep Track Capital, LP
Quarter ended Q3 2025 · Filed November 14, 2025 · Accession 0001856083-25-000006
Total Value
$3.58B
Positions
56
Other Managers
0
Confidential Omitted
No
Holdings (56)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | GUARDANT HEALTH INC | GH | 4,154,086 | $259.5M | 7.24% |
| 2 | IONIS PHARMACEUTICALS INC | IONS | 3,808,144 | $249.1M | 6.95% |
| 3 | CYTOKINETICS INC | CYTK | 4,300,000 | $236.3M | 6.60% |
| 4 | AKERO THERAPEUTICS INC | 00973Y108 | 4,000,978 | $190.0M | 5.30% |
| 5 | APELLIS PHARMACEUTICALS INC | APLS | 8,000,382 | $181.0M | 5.05% |
| 6 | TARSUS PHARMACEUTICALS INC | TARS | 3,000,000 | $178.3M | 4.98% |
| 7 | IMMUNOVANT INC | IMVT | 9,728,845 | $156.8M | 4.38% |
| 8 | DYNAVAX TECHNOLOGIES CORP | 268158201 | 15,726,349 | $156.2M | 4.36% |
| 9 | OCULAR THERAPEUTIX INC | OCUL | 11,932,137 | $139.5M | 3.89% |
| 10 | 89BIO INC | 282559103 | 9,356,171 | $137.5M | 3.84% |
| 11 | STRUCTURE THERAPEUTICS INC | GPCR | 4,215,811 | $118.0M | 3.29% |
| 12 | VIRIDIAN THERAPEUTICS INC | VRDN | 5,380,449 | $116.1M | 3.24% |
| 13 | PROTAGONIST THERAPEUTICS INC | PTGX | 1,715,691 | $114.0M | 3.18% |
| 14 | AXSOME THERAPEUTICS INC | AXSM | 900,000 | $109.3M | 3.05% |
| 15 | VAXCYTE INC | PCVX | 3,000,000 | $108.1M | 3.02% |
| 16 | MAZE THERAPEUTICS INC | MAZE | 3,948,910 | $102.4M | 2.86% |
| 17 | IMMUNOCORE HLDGS PLC | IMCR | 1,800,000 | $65.4M | 1.82% |
| 18 | BRIDGEBIO PHARMA INC | BBIO | 1,200,000 | $62.3M | 1.74% |
| 19 | GERON CORP | GERN | 41,096,522 | $56.3M | 1.57% |
| 20 | TERNS PHARMACEUTICALS INC | TERN | 7,495,000 | $56.3M | 1.57% |
| 21 | NURIX THERAPEUTICS INC | NRIX | 6,057,024 | $56.0M | 1.56% |
| 22 | MBX BIOSCIENCES INC | MBX | 3,150,000 | $55.1M | 1.54% |
| 23 | EXACT SCIENCES CORP | 30063P105 | 1,000,000 | $54.7M | 1.53% |
| 24 | LB PHARMACEUTICALS INC | LBRX | 3,352,804 | $52.9M | 1.48% |
| 25 | CELLDEX THERAPEUTICS INC NEW | CLDX | 2,000,000 | $51.7M | 1.44% |
| 26 | ORUKA THERAPEUTICS INC | ORKA | 2,654,781 | $51.1M | 1.42% |
| 27 | XENON PHARMACEUTICALS INC | XENE | 1,200,000 | $48.2M | 1.34% |
| 28 | COMPASS PATHWAYS PLC | CMPS | 7,859,648 | $45.0M | 1.26% |
| 29 | ANI PHARMACEUTICALS INC | ANIP | 450,000 | $41.2M | 1.15% |
| 30 | BICARA THERAPEUTICS INC | BCAX | 2,426,657 | $38.3M | 1.07% |
| 31 | OLEMA PHARMACEUTICALS INC | OLMA | 3,470,172 | $34.0M | 0.95% |
| 32 | CIDARA THERAPEUTICS INC | 171757206 | 300,000 | $28.7M | 0.80% |
| 33 | UNIQURE NV | QURE | 483,092 | $28.2M | 0.79% |
| 34 | DYNE THERAPEUTICS INC | DYN | 2,000,000 | $25.3M | 0.71% |
| 35 | JADE BIOSCIENCES INC | JBIO | 2,279,892 | $19.7M | 0.55% |
| 36 | RAPT THERAPEUTICS INC | 75382E208 | 751,422 | $19.4M | 0.54% |
| 37 | GH RESEARCH PLC | GHRS | 1,250,000 | $17.9M | 0.50% |
| 38 | MIND MEDICINE MINDMED INC | 60255C885 | 1,500,000 | $17.7M | 0.49% |
| 39 | ENGENE HOLDINGS INC | ENGNW | 2,239,353 | $15.3M | 0.43% |
| 40 | GENMAB A/S | GNMSF | 481,267 | $14.8M | 0.41% |
| 41 | TANGO THERAPEUTICS INC | TNGX | 1,454,562 | $12.2M | 0.34% |
| 42 | CONTEXT THERAPEUTICS INC | CNTX | 7,419,355 | $7.2M | 0.20% |
| 43 | IMAGENEBIO INC | IMA | 878,516 | $7.2M | 0.20% |
| 44 | XENCOR INC | XNCR | 549,439 | $6.4M | 0.18% |
| 45 | CYBIN INC | HELP | 1,000,000 | $5.9M | 0.16% |
| 46 | CORMEDIX INC | CRMD | 500,000 | $5.8M | 0.16% |
| 47 | PEPGEN INC | PEPG | 1,200,000 | $5.5M | 0.15% |
| 48 | CRESCENT BIOPHARMA INC. | CBIO | 453,686 | $5.4M | 0.15% |
| 49 | ALIGOS THERAPEUTICS INC | ALGS | 444,110 | $4.4M | 0.12% |
| 50 | AUTOLUS THERAPEUTICS PLC | AUTL | 2,568,613 | $4.2M | 0.12% |
| 51 | X4 PHARMACEUTICALS INC | XFOR | 1,122,484 | $3.8M | 0.11% |
| 52 | ACADIA PHARMACEUTICALS INC | ACAD | 105,085 | $2.2M | 0.06% |
| 53 | AVALO THERAPEUTICS INC | AVTX | 144,600 | $1.8M | 0.05% |
| 54 | BIOMARIN PHARMACEUTICAL INC | BMRN | 24,856 | $1.3M | 0.04% |
| 55 | ZURA BIO LTD | ZURA | 259,014 | $1.1M | 0.03% |
| 56 | CLIMB BIO INC | CLYM | 509,789 | $1.0M | 0.03% |